Stocks and Investing Stocks and Investing
Wed, April 28, 2021
Tue, April 27, 2021

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Increased Target to $225 on, Apr 27th, 2021


Published on 2024-10-27 16:23:56 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $210 to $225 on, Apr 27th, 2021.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Increased Target to $104 on, Tuesday, March 2nd, 2021
  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $129 on, Friday, January 8th, 2021
Contributing Sources